Caris Life Sciences, Inc.
- CAI
- NASDAQ
- Biotechnology
- Precision Medicine
- AI Molecular Profiling
$30.63
Today −0.26%Quote Oct 20, 2026, 02:55 PM UTC
+2.43%over the last month
Max drawdown −16.0%From 1-month high −4.8%3 months +95.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Caris Life Sciences
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
1,846
Market value
$8.66B
Quote Oct 20
Floor
$30.48
0.5% below price
Resistance
$32.39
5.8% above price
Price vs analyst targets
8 analysts
Lowest target
$22.00Highest target
$33.00
$22.00Highest target
$33.00
- Price $30.63
- Average target $27.25
- Analysts' target range
Analysts' average target sits about 11% lower.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CAIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free